论文部分内容阅读
目的:探讨米非司酮配伍米索前列醇在瘢痕子宫中期妊娠引产中减轻宫缩阵痛,减少产后出血的临床效果。方法:将瘢痕子宫要求行中期妊娠引产的妇女随机分为观察组和对照组,观察组用米非司酮配伍米索前列醇引产,对照组用传统流产药物利凡诺羊膜腔注射。结果:米非司酮配伍米索前列醇在瘢痕子宫中期妊娠引产术中宫颈软化及扩张程度好,宫缩阵痛轻,产时出血量少,无软产道裂伤,产后无需应用加强子宫收缩的药物。结论:米非司酮配伍米索前列醇用于瘢痕子宫中期妊娠引产能有效减轻宫缩阵痛,减少产时产后出血。
Objective: To investigate the clinical effect of mifepristone combined with misoprostol in reducing uterine contractions pain and reducing postpartum hemorrhage in induced abortion of scar uterus. Methods: The women with scar uterus who were asked to give birth in the second trimester of pregnancy were randomly divided into observation group and control group. The observation group was treated with mifepristone and misoprostol. The control group was injected with rivaroxan amniotic fluid. Results: Mifepristone combined with misoprostol in cervical uterine scar induction of miscarriage and dilatation of the degree of good cervix, uterine contraction pain, less bleeding during labor, no soft birth canal laceration, no need to strengthen postpartum uterine contraction drug. Conclusion: The combination of mifepristone and misoprostol for inducing uterine scar pregnancy can effectively reduce uterine contractions pain and reduce postpartum hemorrhage.